zeaxanthin and Cognitive-Dysfunction

zeaxanthin has been researched along with Cognitive-Dysfunction* in 3 studies

Trials

1 trial(s) available for zeaxanthin and Cognitive-Dysfunction

ArticleYear
Lutein and Zeaxanthin Influence Brain Function in Older Adults: A Randomized Controlled Trial.
    Journal of the International Neuropsychological Society : JINS, 2018, Volume: 24, Issue:1

    The present study constitutes the first randomized controlled trial to investigate the relation of lutein (L) and zeaxanthin (Z) to brain function using functional magnetic resonance imaging (fMRI). It was hypothesized that L and Z supplementation in older adults would enhance neural efficiency (i.e., reduce activation) and cognitive performance on a verbal learning task relative to placebo.. A total of 44 community-dwelling older adults (mean age=72 years) were randomly assigned to receive either placebo or L+Z supplementation (12 mg/daily) for 1 year. Neurocognitive performance was assessed at baseline and post-intervention on an fMRI-adapted task involving learning and recalling word pairs. Imaging contrasts of blood-oxygen-level-dependent (BOLD) signal were created by subtracting active control trials from learning and recall trials. A flexible factorial model was employed to investigate the expected group (placebo vs. supplement) by time (baseline vs. post-intervention) interaction in pre-specified regions-of-interest.. L and Z appeared to buffer cognitive decline on the verbal learning task (Cohen's d=.84). Significant interactions during learning were observed in left dorsolateral prefrontal cortex and anterior cingulate cortex (p < .05, family-wise-error corrected). However, these effects were in the direction of increased rather than decreased BOLD signal. Although the omnibus interaction was not significant during recall, within-group contrasts revealed significant increases in left prefrontal activation in the supplement group only.. L and Z supplementation appears to benefit neurocognitive function by enhancing cerebral perfusion, even if consumed for a discrete period of time in late life. (JINS, 2018, 24, 77-90).

    Topics: Aged; Aged, 80 and over; Aging; Cognitive Dysfunction; Dietary Supplements; Female; Gyrus Cinguli; Humans; Independent Living; Lutein; Magnetic Resonance Imaging; Male; Middle Aged; Prefrontal Cortex; Verbal Learning; Zeaxanthins

2018

Other Studies

2 other study(ies) available for zeaxanthin and Cognitive-Dysfunction

ArticleYear
Lifestyles and Cognitive Health: What Older Individuals Can Do to Optimize Cognitive Outcomes.
    JAMA, 2015, Aug-25, Volume: 314, Issue:8

    Topics: Cognition; Cognitive Dysfunction; Dementia; Dietary Supplements; Docosahexaenoic Acids; Eicosapentaenoic Acid; Executive Function; Exercise Therapy; Female; Health Promotion; Humans; Lutein; Macular Degeneration; Male; Sedentary Behavior; Vitamins; Zeaxanthins

2015
Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults.
    Neurobiology of aging, 2014, Volume: 35, Issue:7

    Low carotenoid status (especially of the xanthophylls, lutein [L], and zeaxanthin [Z]) is common in older adults and has been associated with a number of degenerative diseases of the central nervous system ranging from retina (e.g., macular degeneration) to brain (e.g., Alzheimer's disease). In this study, we tested whether retinal measures of L + Z (macular pigment optical density [MPOD]), used as a surrogate for brain L + Z levels, were related to cognitive function when comparing healthy older adults with mildly cognitively impaired older adults. Twenty-four subjects with mild cognitive impairment were compared with 24 matched controls. Subjects were matched with respect to age, body mass index, ethnicity, sex, and smoking status. Degree of cognitive impairment and cognitive ability was determined via structured clinical interview. MPOD was measured psychophysically. In healthy older adults, MPOD was only related to visual-spatial and constructional abilities (p = 0.04). For subjects with mild cognitive impairment (MCI), however, MPOD was broadly related to cognition including the composite score on the mini-mental state examination (p = 0.02), visual-spatial and constructional abilities (p = 0.04), language ability (p = 0.05), attention (p = 0.03), and the total scale on the Repeatable Battery for the Assessment of Neuropsychological Status (p = 0.03). It is possible that L/Z status may be more strongly related to cognition when individuals are considered with established onset of cognitive decline.

    Topics: Aged; Aged, 80 and over; Attention; Brain; Carotenoids; Cognition; Cognitive Dysfunction; Female; Humans; Lutein; Macula Lutea; Male; Neuropsychological Tests; Retinal Pigments; Spatial Behavior; Visual Perception; Xanthophylls; Zeaxanthins

2014